Gabapentin and Pregabalin Use in First Trimester of Pregnancy and Risk of Specific Congenital Anomalies: An IMI ConcePTION European Case-Malformed Control Study

Anna-Belle Beau, Erika Cifuentes Castro, Justine Benevent, Marie Beslay, Laia Barrachina-Bonet, Jorieke E. H. Bergman, Clara Cavero-Carbonell, Alessio Coi, Helen Dolk, Ester Garne, Miriam Gatt, Jonathan Hoareau, Elly Den Hond, Anna Latos-Bielenska, Nathalie Lelong, Mary O’Mahony, Xavier Moisset, Joan Morris, Amanda J. Neville, Joanna Sichitiu, Maria Loane, Christine Damase-Michel

Open source

DOI
10.1007/s40264-026-01672-8
Published
2026-06-02
Container
Drug Safety
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s40264-026-01672-8,
  title = {Gabapentin and Pregabalin Use in First Trimester of Pregnancy and Risk of Specific Congenital Anomalies: An IMI ConcePTION European Case-Malformed Control Study},
  author = {Anna-Belle Beau and Erika Cifuentes Castro and Justine Benevent and Marie Beslay and Laia Barrachina-Bonet and Jorieke E. H. Bergman and Clara Cavero-Carbonell and Alessio Coi and Helen Dolk and Ester Garne and Miriam Gatt and Jonathan Hoareau and Elly Den Hond and Anna Latos-Bielenska and Nathalie Lelong and Mary O’Mahony and Xavier Moisset and Joan Morris and Amanda J. Neville and Joanna Sichitiu and Maria Loane and Christine Damase-Michel},
  year = {2026},
  journal = {Drug Safety},
  doi = {10.1007/s40264-026-01672-8},
  url = {https://doi.org/10.1007/s40264-026-01672-8}
}

RIS

TY  - JOUR
TI  - Gabapentin and Pregabalin Use in First Trimester of Pregnancy and Risk of Specific Congenital Anomalies: An IMI ConcePTION European Case-Malformed Control Study
AU  - Anna-Belle Beau
AU  - Erika Cifuentes Castro
AU  - Justine Benevent
AU  - Marie Beslay
AU  - Laia Barrachina-Bonet
AU  - Jorieke E. H. Bergman
AU  - Clara Cavero-Carbonell
AU  - Alessio Coi
AU  - Helen Dolk
AU  - Ester Garne
AU  - Miriam Gatt
AU  - Jonathan Hoareau
AU  - Elly Den Hond
AU  - Anna Latos-Bielenska
AU  - Nathalie Lelong
AU  - Mary O’Mahony
AU  - Xavier Moisset
AU  - Joan Morris
AU  - Amanda J. Neville
AU  - Joanna Sichitiu
AU  - Maria Loane
AU  - Christine Damase-Michel
PY  - 2026
JO  - Drug Safety
DO  - 10.1007/s40264-026-01672-8
UR  - https://doi.org/10.1007/s40264-026-01672-8
ER  - 

APA

Beau, A., Castro, E. C., Benevent, J., Beslay, M., Barrachina-Bonet, L., Bergman, J. E. H., Cavero-Carbonell, C., Coi, A., Dolk, H., Garne, E., Gatt, M., Hoareau, J., Hond, E. D., Latos-Bielenska, A., Lelong, N., O’Mahony, M., Moisset, X., Morris, J., Neville, A. J., Sichitiu, J., Loane, M., & Damase-Michel, C. (2026). Gabapentin and Pregabalin Use in First Trimester of Pregnancy and Risk of Specific Congenital Anomalies: An IMI ConcePTION European Case-Malformed Control Study. Drug Safety. https://doi.org/10.1007/s40264-026-01672-8

Source records